A recent study by Hu et al. [19] reported that fewer CD8+ T cells were present in those OSCC patients harboring high LLT1 expression in tumor cells (both at the front and the center of tumor tissue), although these differences were not statistically significant. The gene discussed is CLEC2D; the disease is neoplasm.